Published in Cancer Res on April 20, 2011
Screening for Chemical Contributions to Breast Cancer Risk: A Case Study for Chemical Safety Evaluation. Environ Health Perspect (2015) 1.44
The aging of the 2000 and 2011 Hallmarks of Cancer reviews: a critique. J Biosci (2013) 1.08
Targeting of Rac GTPases blocks the spread of intact human breast cancer. Oncotarget (2012) 1.04
Feedback within the inter-cellular communication and tumorigenesis in carcinomas. PLoS One (2012) 0.95
Prenatal exposure to BPA alters the epigenome of the rat mammary gland and increases the propensity to neoplastic development. PLoS One (2014) 0.95
Rational bases for the use of the Immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patients. Int Immunol (2016) 0.94
Tumor and the microenvironment: a chance to reframe the paradigm of carcinogenesis? Biomed Res Int (2014) 0.91
Miniaturized pre-clinical cancer models as research and diagnostic tools. Adv Drug Deliv Rev (2013) 0.89
Is systems biology a promising approach to resolve controversies in cancer research? Cancer Cell Int (2012) 0.89
Platelet-derived growth factor primes cancer-associated fibroblasts for apoptosis. J Biol Chem (2014) 0.88
Systems biology and cancer. Prog Biophys Mol Biol (2011) 0.79
Improving anticancer efficacy of (-)-epigallocatechin-3-gallate gold nanoparticles in murine B16F10 melanoma cells. Drug Des Devel Ther (2014) 0.79
Decay Dynamics of Tumors. PLoS One (2016) 0.79
Cancer Metastases: So Close and So Far. J Natl Cancer Inst (2015) 0.79
Carcinogenesis explained within the context of a theory of organisms. Prog Biophys Mol Biol (2016) 0.76
A novel pathogenic classification of cancers. Cancer Cell Int (2014) 0.76
Infiltrating T Cells Promote Bladder Cancer Progression via Increasing IL1→Androgen Receptor→HIF1α→VEGFa Signals. Mol Cancer Ther (2016) 0.76
Molecular mechanism of the "feedback loop" model of carcinogenesis. Commun Integr Biol (2012) 0.75
Hallmarks of cancer: the next generation. Cell (2011) 140.01
The ground state of embryonic stem cell self-renewal. Nature (2008) 19.44
Tumour evolution inferred by single-cell sequencing. Nature (2011) 19.13
DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science (2011) 10.26
Evolution and tinkering. Science (1977) 9.07
Epigenetics in cancer. Carcinogenesis (2009) 7.49
Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers. Nat Rev Cancer (2010) 6.27
Exploring the genomes of cancer cells: progress and promise. Science (2011) 6.16
Reprogramming metastatic tumour cells with embryonic microenvironments. Nat Rev Cancer (2007) 3.17
Totipotency and normal differentiation of single teratocarcinoma cells cloned by injection into blastocysts. Proc Natl Acad Sci U S A (1976) 3.12
Tumor reversion: correction of malignant behavior by microenvironmental cues. Int J Cancer (2003) 3.02
Combating environmental causes of cancer. N Engl J Med (2011) 2.59
Regulation of quiescence in lymphocytes. Trends Immunol (2003) 2.58
An attack on cytologism. Lancet (1962) 2.23
Chromosomal variation in neurons of the developing and adult mammalian nervous system. Proc Natl Acad Sci U S A (2001) 2.20
The streaming liver. Liver (1985) 1.56
Somatic mutations are frequent and increase with age in human kidney epithelial cells. Hum Mol Genet (1996) 1.50
Theories of carcinogenesis: an emerging perspective. Semin Cancer Biol (2008) 1.49
Stromal regulation of neoplastic development: age-dependent normalization of neoplastic mammary cells by mammary stroma. Am J Pathol (2005) 1.48
Personalized genetic prediction: too limited, too expensive, or too soon? Ann Intern Med (2009) 1.23
On physicalism and downward causation in developmental and cancer biology. Acta Biotheor (2008) 1.18
Emergentism as a default: cancer as a problem of tissue organization. J Biosci (2005) 1.12
Beyond the oncogene paradigm: understanding complexity in cancerogenesis. Acta Biotheor (2008) 1.00
Model organisms and human health. Science (2010) 0.84
Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev (2009) 9.60
Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev (2012) 6.12
Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod Toxicol (2007) 4.04
Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr Rev (2008) 4.03
The stroma as a crucial target in rat mammary gland carcinogenesis. J Cell Sci (2004) 3.83
Why public health agencies cannot depend on good laboratory practices as a criterion for selecting data: the case of bisphenol A. Environ Health Perspect (2008) 3.27
Evidence of altered brain sexual differentiation in mice exposed perinatally to low, environmentally relevant levels of bisphenol A. Endocrinology (2006) 2.63
Prenatal bisphenol A exposure induces preneoplastic lesions in the mammary gland in Wistar rats. Environ Health Perspect (2007) 2.29
Endocrine disruptors and reproductive health: the case of bisphenol-A. Mol Cell Endocrinol (2006) 2.22
Perinatal exposure to bisphenol-A alters peripubertal mammary gland development in mice. Endocrinology (2005) 2.14
Induction of mammary gland ductal hyperplasias and carcinoma in situ following fetal bisphenol A exposure. Reprod Toxicol (2006) 1.92
Exposure to environmentally relevant doses of the xenoestrogen bisphenol-A alters development of the fetal mouse mammary gland. Endocrinology (2006) 1.90
An evaluation of evidence for the carcinogenic activity of bisphenol A. Reprod Toxicol (2007) 1.83
Bisphenol A: Perinatal exposure and body weight. Mol Cell Endocrinol (2009) 1.82
Long-term effects of fetal exposure to low doses of the xenoestrogen bisphenol-A in the female mouse genital tract. Biol Reprod (2005) 1.79
Biotransformations of bisphenol A in a mammalian model: answers and new questions raised by low-dose metabolic fate studies in pregnant CD1 mice. Environ Health Perspect (2003) 1.62
Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing. Fertil Steril (2008) 1.60
Perinatal exposure to the xenoestrogen bisphenol-A induces mammary intraductal hyperplasias in adult CD-1 mice. Reprod Toxicol (2008) 1.53
Theories of carcinogenesis: an emerging perspective. Semin Cancer Biol (2008) 1.49
Stromal regulation of neoplastic development: age-dependent normalization of neoplastic mammary cells by mammary stroma. Am J Pathol (2005) 1.48
A novel 3D in vitro culture model to study stromal-epithelial interactions in the mammary gland. Tissue Eng Part C Methods (2008) 1.45
Mammalian development in a changing environment: exposure to endocrine disruptors reveals the developmental plasticity of steroid-hormone target organs. Evol Dev (2002) 1.43
Perinatal exposure to environmentally relevant levels of bisphenol A decreases fertility and fecundity in CD-1 mice. Environ Health Perspect (2010) 1.41
Endocrine disruptors: from Wingspread to environmental developmental biology. J Steroid Biochem Mol Biol (2002) 1.33
Perinatal bisphenol A exposure increases estrogen sensitivity of the mammary gland in diverse mouse strains. Environ Health Perspect (2007) 1.28
The mammary gland response to estradiol: monotonic at the cellular level, non-monotonic at the tissue-level of organization? J Steroid Biochem Mol Biol (2006) 1.23
Bisphenol A alters the development of the rhesus monkey mammary gland. Proc Natl Acad Sci U S A (2012) 1.21
Importance of dosage standardization for interpreting transcriptomal signature profiles: evidence from studies of xenoestrogens. Proc Natl Acad Sci U S A (2006) 1.16
The microenvironment determines the breast cancer cells' phenotype: organization of MCF7 cells in 3D cultures. BMC Cancer (2010) 1.16
Plausibility of stromal initiation of epithelial cancers without a mutation in the epithelium: a computer simulation of morphostats. BMC Cancer (2009) 1.15
Endocrine-disrupting effects of cattle feedlot effluent on an aquatic sentinel species, the fathead minnow. Environ Health Perspect (2004) 1.14
Perinatally administered bisphenol a as a potential mammary gland carcinogen in rats. Environ Health Perspect (2013) 1.13
Hormone replacement therapy, cancer, controversies, and women's health: historical, epidemiological, biological, clinical, and advocacy perspectives. J Epidemiol Community Health (2005) 1.11
Low-dose BPA exposure alters the mesenchymal and epithelial transcriptomes of the mouse fetal mammary gland. PLoS One (2013) 1.11
The aging of the 2000 and 2011 Hallmarks of Cancer reviews: a critique. J Biosci (2013) 1.08
Regulatory decisions on endocrine disrupting chemicals should be based on the principles of endocrinology. Reprod Toxicol (2013) 1.07
Estrogenic activity of polychlorinated biphenyls present in human tissue and the environment. Environ Sci Technol (2006) 1.06
The role of collagen reorganization on mammary epithelial morphogenesis in a 3D culture model. Biomaterials (2010) 1.05
Flawed experimental design reveals the need for guidelines requiring appropriate positive controls in endocrine disruption research. Toxicol Sci (2010) 0.99
Effects of low doses of bisphenol A on the metabolome of perinatally exposed CD-1 mice. Environ Health Perspect (2013) 0.96
The effect of stromal components on the modulation of the phenotype of human bronchial epithelial cells in 3D culture. Biomaterials (2011) 0.95
Interlaboratory comparison of four in vitro assays for assessing androgenic and antiandrogenic activity of environmental chemicals. Environ Health Perspect (2004) 0.87
Hormonal regulation of epithelial organization in a three-dimensional breast tissue culture model. Tissue Eng Part C Methods (2013) 0.86
Competing views on cancer. J Biosci (2014) 0.86
In search of principles for a Theory of Organisms. J Biosci (2015) 0.83
Dual regulation of breast tubulogenesis using extracellular matrix composition and stromal cells. Tissue Eng Part A (2011) 0.82
Mechanism of androgen action on cell proliferation: AS3 protein as a mediator of proliferative arrest in the rat prostate. Endocrinology (2002) 0.81
The male mammary gland: a target for the xenoestrogen bisphenol A. Reprod Toxicol (2013) 0.80
Breast epithelial tissue morphology is affected in 3D cultures by species-specific collagen-based extracellular matrix. J Biomed Mater Res A (2012) 0.80
Systems biology and cancer. Prog Biophys Mol Biol (2011) 0.79
Lack of c-kit receptor promotes mammary tumors in N-nitrosomethylurea-treated Ws/Ws rats. Cancer Cell Int (2008) 0.79
Histological analysis of low dose NMU effects in the rat mammary gland. BMC Cancer (2009) 0.79
Correcting an error. Re: Dr. Harris's response to: Soto AM, Sonnenschein C. 2004. The somatic mutation theory of cancer: growing problems with the paradigm? BioEssays 26: 1097-1107. Bioessays (2006) 0.78
Why systems biology and cancer? Semin Cancer Biol (2011) 0.78
Characterization of a plasma membrane-resident albumin-binding protein associated with the proliferation of estrogen-target, serum-sensitive cells. Steroids (2003) 0.77
Shining a light on sunscreens. Endocrinology (2005) 0.76
Carcinogenesis and metastasis now in the third dimension--what's in it for pathologists? Am J Pathol (2006) 0.76
Special issue on the topic: Role of endocrine disruptors from the environment in the aetiology of obesity and diabetes. Mol Cell Endocrinol (2009) 0.76
And yet another epicycle. Bioessays (2006) 0.75
Response to "In defense of the somatic mutation theory of cancer". DOI: 10.1002/bies.201100022. Bioessays (2011) 0.75
[Endocrine disruptors: a very personal story with multiple personalities]. Gac Sanit (2002) 0.75
Are times a' changin' in carcinogenesis? Endocrinology (2005) 0.75